Public Health Literature Review of Fragile X Syndrome

Pediatrics. 2017 Jun;139(Suppl 3):S153-S171. doi: 10.1542/peds.2016-1159C.

Abstract

Objectives: The purpose of this systematic literature review is to describe what is known about fragile X syndrome (FXS) and to identify research gaps. The results can be used to help inform future public health research and provide pediatricians with up-to-date information about the implications of the condition for individuals and their families.

Methods: An electronic literature search was conducted, guided by a variety of key words. The search focused on 4 areas of both clinical and public health importance: (1) the full mutation phenotype, (2) developmental trajectories across the life span, (3) available interventions and treatments, and (4) impact on the family. A total of 661 articles were examined and 203 were included in the review.

Results: The information is presented in the following categories: developmental profile (cognition, language, functional skills, and transition to adulthood), social-emotional profile (cooccurring psychiatric conditions and behavior problems), medical profile (physical features, seizures, sleep, health problems, and physiologic features), treatment and interventions (educational/behavioral, allied health services, and pharmacologic), and impact on the family (family environment and financial impact). Research gaps also are presented.

Conclusions: The identification and treatment of FXS remains an important public health and clinical concern. The information presented in this article provides a more robust understanding of FXS and the impact of this complex condition for pediatricians. Despite a wealth of information about the condition, much work remains to fully support affected individuals and their families.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adult
  • Caregivers / psychology
  • Child
  • Cross-Sectional Studies
  • DNA Mutational Analysis
  • Delivery of Health Care
  • Developmental Disabilities / diagnosis
  • Developmental Disabilities / genetics
  • Diagnosis, Differential
  • Female
  • Fragile X Mental Retardation Protein / genetics
  • Fragile X Syndrome / diagnosis
  • Fragile X Syndrome / genetics*
  • Fragile X Syndrome / psychology
  • Fragile X Syndrome / therapy
  • Genetic Testing
  • Humans
  • Language Development Disorders / diagnosis
  • Language Development Disorders / genetics
  • Language Development Disorders / psychology
  • Language Development Disorders / therapy
  • Male
  • Parenting / psychology
  • Phenotype
  • Prognosis
  • Public Health*
  • Social Adjustment
  • Trinucleotide Repeats / genetics

Substances

  • FMR1 protein, human
  • Fragile X Mental Retardation Protein